Differential effects of progestogens on breast cancer cell lines

Maturitas

Volumn 46, Issue SUPPL. 1, 2003, Pages 55-58

  Franke, Henk R ^a   Vermes, Istvan ^a  

^a MEDISCH SPECTRUM TWENTE   (Netherlands)

Author keywords

Breast cancer; In vitro research; Progestogens

Indexed keywords

DIENOGEST; DIHYDRODYDROGESTERONE; DRUG METABOLITE; DYDROGESTERONE; ESTRADIOL; GESTAGEN; MEDROXYPROGESTERONE ACETATE; NORETHISTERONE ACETATE; PROGESTERONE; TIBOLONE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; HORMONE ACTION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY;

NETA;

EID: 0344304696     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2003.09.019     Document Type: Article

References (17)

1. Stoll B.A. Hormone replacement therapy in women treated for breast cancer. Eur. J. Cancer Clin. Oncol. 25:1989;1909-1913.
2. DiSaia P.J., Brewster W.R., Ziogas A., Anton-Culver H. Breast cancer survival and hormone replacement therapy. A cohort analysis. Am. J. Clin. Oncol. 23:2000;541-545.
3. O'Meara E.S., Rossing M.A., Daling J.R., Elmoree J.G., Barlow W.E., Weiss N.S. Hormone replacement therapy after a diagnosis of breast cancer in relation to recurrence and mortality. J. Nat. Cancer Inst. 93:2001;754-762.
4. Marttunen M.B., Hietanen P., Pyrhönen S., Tiitinen A., Ylikorkala O. A prospective study on women with a history of breast cancer and with or without estrogen replacement therapy. Maturitas. 39:2001;217-225.
5. Natrajan P.K., Gambrell R.D. Estrogen replacement therapy in patients with early breast cancer. Am. J. Obstet. Gynecol. 62:2002;435-443.
6. Chang K.J., Lee T.T., Linares-Cruz G., Fournier S., de Lignieres B. Influences of percutaneous administration of estradiol and progesterone on human breast epithelial cell cycle in vivo. Fertil. Steril. 63:1995;785-791.
7. Gompel A., Somai S., Chaouat M.et al. Hormonal regulation of apoptosis in breast cells and tissues. Steroids. 65:2000;593-598.
8. Franke H.R. The induction of apoptosis in human breast cancer cells in vitro by hormonal manipulation. Climacteric. 5(Suppl. 1):2002;216-217.
9. Franke H.R., Vermes I. The effect of continuous combined 17β-oestradiol and dihydrodydrogesterone on apoptotic cell death and proliferation of human breast cancer cells in vitro. Eur. J. Cancer. 38(Suppl. 6):2002;69-70.
10. Franke H.R., Kole S., Ciftci Z., Haanen C., Vermes I. In vitro effects of estradiol, dydrogesterone, tamoxifen and cyclophosphamide on proliferation vs. death in human breast cancer cells. Cancer Lett. 190:2003;113-118.
11. Vermes I., Haanen C., Reutelingsperger C. Flow cytometry of apoptotic cell death. J. Immunol. Methods. 243:2000;167-190.
12. Marx P.T.J., Mulder A.B., Van den Bergh F.A.J.T.M., Overbeeke R., Haanen C., Vermes I. Apoptosis inducers endotoxin and Fas-ligation enhance the expression of vascular endothelial growth factor in human endothelial cells. Endothelium. 6:1999;335-340.
13. Nicoletti I., Migliorati G., Pagliacci M.C., Grignani F., Riccardi C. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J. Immunol. Methods. 138:1991;271-279.
14. Lippert C., Seeger H., Wallwiener D., Mueck A.O. Comparison of the effects of continuous combined and sequential combined medroxyprogesterone acetate-estradiol treatment on the proliferation of MCF-7 cells. Climacteric. 3:2000;271-277.
15. Groshong S.D., Owen G.I., Grimison B.et al. Biphasic regulation of breast cancer cell growth by progesterone: role of the cyclin-dependent kinase inhibitors, p21 and p27(Kip1). Mol. Endocrinol. 11:1997;1593-1607.
16. Foster J.S., Henley D.C., Ahamed S., Wimalasena J. Estrogens and cell-cycle regulation in breast cancer. Trends Endocrinol. Metabol. 12:2001;320-327.
17. Yu Q., Geng Y., Sicinski P. Specific protection against breast cancers by Cyclin D1 ablation. Nature. 411:2001;1017-10121.